Dynavax Technologies Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Hey, guys, my name is Rob Palermo. I'm part of the biotech research team here at Goldman Sachs. Happy to be here today at the Annual Healthcare Conference with Ryan Spencer, CEO of Dynavax Technologies. We're going to go through presentation today, and then time permitting, we can field some questions if there are any submitted. So how about -- you can take it away, Ryan.
Thanks, Rob. And thank you all for joining us today. I'm Ryan Spencer, Chief Executive Officer of Dynavax Technologies, and I'm excited to share the Dynavax story with you, which, we believe, provides a compelling investment opportunity.
In this corporate overview, we will be making forward-looking statements that are subject to risks and uncertainties as identified on this slide and in our filings with the SEC, which provide details on our business and the associated investment risk, which we encourage you to review.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |